Scientific Advisory Board
The quality management of MaxSynBio is ensured through an evaluation concept and by the scientific advisory board.
The evaluation concept of MaxSynBio was elaborated in close cooperation with the Projektträger Jülich (funding organization) and the headquarters of the Max Planck Society. This evaluation concept takes into account the specific regulations of the grant approval for MaxSynBio (25 July 2014) and the general regulations for grant approvals (BNBest-BMBF 98) by the Bundesministerium für Bildung und Forschung (Federal Ministry for Education and Research in Germany, BMBF, BNBest-BMBF 98).
The scientific advisory board was nominated by the President of the Max Planck Society, Porf. Dr. Martin Stratmann. The SAB evaluates MaxSynBio at annual intervals on the basis of the annual status report and the annual status seminar.